Close
  Indian J Med Microbiol
 

Figure 4 :Accelerating clinical development of product portfolio by using phase 0 trials. (IND, investigational new drug application; ExpIND, exploratory IND; PK, pharmacokinetic; PD, pharmacodynamic; NDA, new drug application)

Figure 4 :Accelerating clinical development of product portfolio by using phase 0 trials. (IND, investigational new drug application; ExpIND, exploratory IND; PK, pharmacokinetic; PD, pharmacodynamic; NDA, new drug application)